Literature DB >> 28598788

CROI 2017: Basic Science Review.

Mario Stevenson1.   

Abstract

The Conference on Retroviruses and Opportunistic Infections (CROI) continues to be the preeminent gathering for HIV/AIDS researchers. It provides a forum in which investigators involved in all aspects of research on HIV/AIDS and related conditions can present and be updated on the latest scientific developments in the field. In 2017, basic research continued to be strongly represented at the conference. Most of the presentations focused on mechanisms of viral persistence in the face of effective antiretroviral therapy as well as approaches to measuring viral reservoirs and intervening in those reservoirs. The intermix of basic and clinical research presentations provided a dynamic forum for the sharing of knowledge that is crucial to moving the field forward.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28598788      PMCID： PMC5677041     

Source DB:  PubMed          Journal:  Top Antivir Med        ISSN： 2161-5853


  8 in total

1.  HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects.

Authors:  Maria J Buzón; Marta Massanella; Josep M Llibre; Anna Esteve; Viktor Dahl; Maria C Puertas; Josep M Gatell; Pere Domingo; Roger Paredes; Mark Sharkey; Sarah Palmer; Mario Stevenson; Bonaventura Clotet; Julià Blanco; Javier Martinez-Picado
Journal:  Nat Med       Date:  2010-03-14       Impact factor: 53.440

2.  HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells.

Authors:  F Maldarelli; X Wu; L Su; F R Simonetti; W Shao; S Hill; J Spindler; A L Ferris; J W Mellors; M F Kearney; J M Coffin; S H Hughes
Journal:  Science       Date:  2014-06-26       Impact factor: 47.728

3.  HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation.

Authors:  Nicolas Chomont; Mohamed El-Far; Petronela Ancuta; Lydie Trautmann; Francesco A Procopio; Bader Yassine-Diab; Geneviève Boucher; Mohamed-Rachid Boulassel; Georges Ghattas; Jason M Brenchley; Timothy W Schacker; Brenna J Hill; Daniel C Douek; Jean-Pierre Routy; Elias K Haddad; Rafick-Pierre Sékaly
Journal:  Nat Med       Date:  2009-06-21       Impact factor: 53.440

4.  Detection of Zika virus RNA in whole blood of imported Zika virus disease cases up to 2 months after symptom onset, Israel, December 2015 to April 2016.

Authors:  Yaniv Lustig; Ella Mendelson; Nir Paran; Sharon Melamed; Eli Schwartz
Journal:  Euro Surveill       Date:  2016-06-30

5.  The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption.

Authors:  Jonathan Z Li; Behzad Etemad; Hayat Ahmed; Evgenia Aga; Ronald J Bosch; John W Mellors; Daniel R Kuritzkes; Michael M Lederman; Michael Para; Rajesh T Gandhi
Journal:  AIDS       Date:  2016-01-28       Impact factor: 4.177

6.  Increase in 2-long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV infection: a randomized, placebo-controlled trial.

Authors:  Hiroyu Hatano; Matthew C Strain; Rebecca Scherzer; Peter Bacchetti; Deborah Wentworth; Rebecca Hoh; Jeffrey N Martin; Joseph M McCune; James D Neaton; Russell P Tracy; Priscilla Y Hsue; Douglas D Richman; Steven G Deeks
Journal:  J Infect Dis       Date:  2013-08-23       Impact factor: 5.226

7.  High-throughput detection of miRNAs and gene-specific mRNA at the single-cell level by flow cytometry.

Authors:  Filippos Porichis; Meghan G Hart; Morgane Griesbeck; Holly L Everett; Muska Hassan; Amy E Baxter; Madelene Lindqvist; Sara M Miller; Damien Z Soghoian; Daniel G Kavanagh; Susan Reynolds; Brett Norris; Scott K Mordecai; Quan Nguyen; Chunfai Lai; Daniel E Kaufmann
Journal:  Nat Commun       Date:  2014-12-04       Impact factor: 14.919

8.  Prolonged Detection of Zika Virus in Vaginal Secretions and Whole Blood.

Authors:  Kristy O Murray; Rodion Gorchakov; Anna R Carlson; Rebecca Berry; Lilin Lai; Muktha Natrajan; Melissa N Garcia; Armando Correa; Shital M Patel; Kjersti Aagaard; Mark J Mulligan
Journal:  Emerg Infect Dis       Date:  2017-01-15       Impact factor: 6.883
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.